Our Team
Experienced Management Team of Innovators
Delta4’s team includes senior leaders and industry professionals with expertise in computational biology, bioinformatics, pharmaceuticals, and finance.
Delta4’s team includes senior leaders and industry professionals with expertise in computational biology, bioinformatics, pharmaceuticals, and finance.
Kurt Herpel, MBA
CEO, Ex-Merck, Takeda
Senior pharma executive with 20+ years of experience in leading organisations. Multifaced leadership roles in start-ups and smaller enterprises beyond pharmaceuticals.
Klaus Kratochwill, PhD
CSO
Translational researcher with 15 years of experience in omics data generation and analysis. Lead for the company’s scientific activities. Visiting researcher at Harvard Medical School.
Alfred Steininger, MBA
CFO, Ex-Raiffeisen, St. Galler
Kantonalbank
Financial professional with 20+ years of experience in banking and capital markets.
Previous experience in multiple international organizations, including large and small size firms.
Paul Perco, PhD
Computational Biology Lead
Kinga Keska-Izworska, PhD
Application Scientist, Computational Biologist
Dorota Wojenska, MA
Executive Assistant, Communication Manager
Matthias Ley, MSc
Lead Software Engineer
Lucas Fillinger, PhD
Application Scientist, Computational Biologist
Samuel Walter, MSc
Application Scientist, Computational Biologist
Andreas Heinzel, MSc
ML/AI Specialist, Hyper-C inventor, lecturer MedUni Wien
Peter Andorfer, PhD
Application Scientist, Computational Biologist
Walter Heindl
Financial Council, Ex-Nomura
Christoph Aufricht
Top KOL & Medical council
Hans Lehrach
Systems Biology Expert & Pioneer in NGS data
Kurt Herpel
CEO
Kurt Herpel (CEO) is a pharma executive with vast experience in leading organisations. Besides big pharma, he is experienced in start-up situations and smaller enterprises.
Klaus Kratochwill
CSO
Klaus Kratochwill (CSO) is a translational researcher, biochemist by training. He is an expert for omics data generation and analysis. In Delta4, he is responsible for coordinating all scientific activities.
Alfred Steininger
CFO
Alfred Steininger (CFO) is a financial professional with a deep knowledge in banking and capital markets. He has worked in a couple of different countries and for both large and small organizations.
Dorota Wojenska
Executive Assistant, Communication Manager
Dorota Wojenska (Executive Assistant, Communication Manager) has over a decade of experience in the pharmaceutical trade, with a diverse skill set spanning Sales, Quality Management, Administrative Support, and the coordination of complex Media Projects.
Paul Perco
Computational
Biology Lead
Paul Perco is an expert in computational biology, bioinformatics and biostatistics for digital drug discovery.
Kinga Keska-Izworska
Application Scientist, Computational Biologist
Kinga Keska-Izworska is a bioinformatics researcher with a solid background in omics data analysis and experience in international academic and industry research settings.
Lucas Fillinger is a molecular biologist versed in the analysis of heterogeneous multivariate datasets and biostatistics.
Peter Andorfer is an expert in molecular and computational biology, with broad expertise ranging from gene therapy and protein engineering to antibody research and drug discovery.
Samuel Walter
Application Scientist, Computational Biologist
Samuel Walter is a bioinformatician experienced in working with various omics data, data integration and data analysis.
Matthias Ley
Lead Software Engineer
Matthias Ley is a full-stack software engineer with a strong background in interdisciplinary software development.
Andreas Heinzel
Bio-IT Specialist
Andreas Heinzel is an experienced IT specialist with a focus on bioinformatics.
Enrico Bono
Application Scientist, Computational Biologist
Enrico Bono is an MSCA PhD student in the EU-funded PICKED (Personalized Medicine in Chronic Kidney Disease) project with a strong passion for machine learning (ML), artificial intelligence (AI), and multi-omics approaches for advancing precision medicine.
Louiza Galou
Application Scientist, Computational Biologist
Louiza Galou is an MSCA-funded PhD researcher within the EU Horizon Europe PROMOTE consortium (Prostate Cancer Omics Mediated Intervention), driven by a strong passion for applying artificial intelligence to solve complex biomedical challenges. Deeply motivated by the transformative potential of computational biology, her research explores how AI can be leveraged to decode the intricate biological underpinnings of disease, with the ultimate goal of advancing precision diagnostics and guiding therapeutic decision-making.
Fabio Baumgärtel
Bioinformatician
Fabio Baumgärtel is a bioinformatician specializing in the processing and visualization of biomedical data.
Walter Heindl
Council Member
Walter Heindl is a financial expert with more than 25 years of experience in Investment Banking / Capital Markets, combined with a strong background in leadership and strategy.
Christoph Aufricht
Council Member
Christoph Aufricht is a translational medical researcher and an expert for drug development in nephrology and rare diseases.
Hans Lehrach
Systems Biology Expert & Entrepreneur
Hans Lehrach was among the initiators of the Human Genome Project and is a pioneer in the application of next generation sequencing techniques and systems medicine for the development of personalized therapies.
Doron Lancet
Pioneer of Systems Biology
Doron Lancet is one of the pioneers of systems biology in the context of human disease. He is head of the Crown Human Genome Center at the Weizmann Institute of Science and is well-known for creating the widely-used GeneCards® system.
Larry Greenbaum
Medical Expert
Larry Greenbaum is a leading pediatric nephrologist and a well-known international expert for kidney disease.